Join to View Full Profile
855 Montgomery StSuite 100Fort Worth, TX 76107
Phone+1 817-735-0349
Dr. Slade is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Allergy and Immunology, 1983 - 1986- University of MichiganResidency, Pediatrics, 1981 - 1983
SUNY Upstate Medical UniversityResidency, Pediatrics, 1980 - 1981
SUNY Upstate Medical UniversityClass of 1980
Certifications & Licensure
MN State Medical License 1995 - 2025
TX State Medical License 2011 - 2025
PA State Medical License 1990 - 1996
MI State Medical License 1981 - 1988
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics
Clinical Trials
- Santyl vs. Sharp Debridement of Diabetic Foot Wounds Start of enrollment: 2010 Feb 01
Publications & Presentations
PubMed
- 5 citationsOne-year safety, healing and amputation rates of Wagner 3-4 diabetic foot ulcers treated with cryopreserved umbilical cord (TTAX01).William A. Marston, John C. Lantis, Stephanie C. Wu, Aksone Nouvong, John Randolph Clements
Wound Repair and Regeneration. 2020-05-09 - 20 citationsAn open-label trial of cryopreserved human umbilical cord in the treatment of complex diabetic foot ulcers complicated by osteomyelitis.William A. Marston, John C. Lantis, Stephanie C. Wu, Aksone Nouvong, Tommy D. Lee
Wound Repair and Regeneration. 2019-08-19 - 13 citationsOpioids' Effect on Healing of Venous Leg Ulcers.Ingrid Herskovitz, Flor Macquhae, Jaime E. Dickerson, D. Innes Cargill, Herbert B. Slade
The Journal of Investigative Dermatology. 2017-12-01
Press Mentions
Effects of a New Enzymatic Debrider (SN514-066b) on Eschar Protein Digestion, Burn Wound Debridement, and Healthy Skin IrritationJanuary 24th, 2025- Taiwan Made Innovation: TissueTechAugust 21st, 2021
- TissueTech Furthers Late-Phase Research of Biologic Candidate TTAX01 to Treat Advanced Wagner Grade 3-4 Diabetic Foot UlcersNovember 12th, 2020
- Join now to see all
Grant Support
- Antibody Clonotype Analysis Using HIV Synthetic PeptidesNational Institute Of Allergy And Infectious Diseases1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
